Logo-bi
Review

1. The Role of Epidermal Growth Factor Receptor in Diabetes-Induced Cardiac Dysfunction
Saghir Akhtar*, Ibrahim Fadil Benter
Bioimpacts. 2013;3(1): 5-9. doi: 10.5681/bi.2013.008
PMCID: PMC3648911     PMID: 23678464     Scopus ID: 84876693184    
Article
PDF
XML
Cited By:
40
17
0
Original Research

2. Gap Junctions: The Claymore for Cancerous Cells
Masoud Asadi-Khiavi, Hossein Hamzeiy*, Sajjad Khani, Ailar Nakhlband, Jaleh Barar* ORCID
Bioimpacts. 2011;1(2): 113-119. doi: 10.5681/bi.2011.015
PMCID: PMC3648953     PMID: 23678415     Scopus ID: 84874688024    
Article
PDF
XML
Cited By:
5
2
0
Original Research

3. Water-soluble pristine C60 fullerene attenuates acetaminophen-induced liver injury
Halyna Kuznietsova* ORCID, Oksana Lynchak, Natalia Dziubenko, Tetyana Herheliuk, Yuriy Prylutskyy, Volodymyr Rybalchenko, Uwe Ritter
Bioimpacts. 2019;9(4): 227-237. doi: 10.15171/bi.2019.28
PMCID: PMC6879707     PMID: 31799159     Scopus ID: 85077112447    
Article
PDF
Full Text
XML
Cited By:
13
3
16
Oxidative stress has been suggested the main trigger and pathological mechanism of toxic liver injury. Powerful free radical scavenger ะก60 fullerene diminishes the signs of acute and chronic liver injury and inhibits EGFR expression in liver cells.
Editorial

4. Targeting long non-coding RNAs as new modulators in anti-EGFR resistance mechanisms

Mostafa Akbarzadeh-Khiavi ORCID, Azam Safary ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2024;14(1): 27696. doi: 10.34172/bi.2023.27696
PMCID: PMC10844586     PMID: 38327631     Scopus ID: 85175801625    
Article
PDF
Full Text
XML
Cited By:
2
0
0
Original Article

5. Unravelling benzazepines and aminopyrimidine as multi-target therapeutic repurposing drugs for EGFR V774M mutation in neuroglioma patients
Jitender Singh ORCID, Krishan L Khanduja, Pramod K Avti* ORCID
Bioimpacts. 2024;14(3): 28876. doi: 10.34172/bi.2023.28876
PMCID: PMC11199933     PMID: 38938756     Scopus ID: 85179388570    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
0
0
0
Original Article

6. Nanobody-functionalized liposomal doxorubicin: A novel strategy for angiogenesis suppression via VEGFR2 targeting
Aezam Akbari ORCID, Azadeh Ghaffari, Fahimeh Haji-Ahmadi, Vahideh Farzam Rad, Mahdi Behdani, Hamidreza Kheiri-Manjili, Cobra Moradian, Davoud Ahmadvand* ORCID
Bioimpacts. 2025;15: 30707 | Published on: 2025 Apr 06. doi: 10.34172/bi.30707
PMCID: PMC12204814     PMID: 40584910     Scopus ID: 105002140178    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
0
0
2
Review

7. Potential role of epidermal growth factor receptors (EGFR) signaling in the pathogenesis and management of hepatocellular carcinoma
Samah Saleh Ahmed Al-Awadhi ORCID, Prakash Patil, Praveenkumar Shetty, Padma K Shetty, Reshma A Shetty, Vijith V Shetty* ORCID
Bioimpacts. 2025;15: 30905 | Published on: 2025 Jul 01. doi: 10.34172/bi.30905
PMCID: PMC12319217     PMID: 40761521     Scopus ID: 105010077745    
Article
PDF
Full Text
XML
Cited By:
0
0
0
Review

8. Allosteric ligand-driven smart nanoconjugates for mutation-selective EGFR targeting: A precision approach to overcoming tyrosine kinase inhibitor resistance
Dilpreet Singh* ORCID, Akshay Kumar, Vir Vikram Sharma
Bioimpacts. 2025;15: 31475 | Published on: 2025 Nov 10. doi: 10.34172/bi.31475
Article
PDF
Suppl 1
XML
Cited By:
0
0
0

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons